1.
Pemmaraju N, Kantarjian H, Shan J, Jabbour E, Quintas-Cardama A, Verstovsek S, Ravandi F, Wierda W, O’Brien S, Cortes J. Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy. Haematologica [Internet]. 2012Jul.13 [cited 2026Nov.16];97(7):1029-35. Available from: https://haematologica.org/article/view/6346